Latest filing published 21 Aug 2018 for Evoke Pharma Inc, €951k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
LVP GP III, LLC: trading record in brief
LVP GP III, LLC is a declared insider of Evoke Pharma Inc, with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 30 September 2013 and the latest from 20 August 2018.
Every open-market trade on record is a purchase: 3 purchases worth €1.0M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2018, the count stands at 3 purchases and no sales.
A typical purchase (the median) is worth €48k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
On 21 August 2018 came the latest disclosure, an open-market purchase for €951k in Evoke Pharma Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to LVP GP III, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 465,116 shares@ US$2.3593.0% of flowCommon StockSEC:0001209191-18-047750:0Canonical exit: 18 Nov 2018 (T+90)
- 23,256 shares@ US$2.354.7% of flowCommon StockSEC:0001209191-18-047750:1Canonical exit: 18 Nov 2018 (T+90)
- 11,628 shares@ US$2.352.3% of flowCommon StockSEC:0001209191-18-047750:2Canonical exit: 18 Nov 2018 (T+90)
- 1,054,262 sharesCommon StockSEC:0001209191-13-046790:0
- 52,711 sharesCommon StockSEC:0001209191-13-046790:1
- 26,356 sharesCommon StockSEC:0001209191-13-046790:2
6 of 6 declarations